NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,481.9 Cr | 21.7% | 27.8% | 24.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹282,845.0 Cr | -2.4% | 17.5% | 0.1% | Stock Analytics | |
| REDINGTON | ₹19,204.3 Cr | -5.8% | -2% | 3.4% | Stock Analytics | |
| HONASA CONSUMER | ₹9,987.2 Cr | 2% | 12.7% | 34.9% | Stock Analytics | |
| MMTC | ₹9,231.0 Cr | -3.1% | -3.7% | 10.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,141.1 Cr | -6.8% | 1% | 34.5% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 21.7% |
27.8% |
24.8% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses